United Kingdom · Question · Written question
UIN 22191
Rare Diseases: Drugs
Original
Introduced
25 June 2021
Last action
1 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 July 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of how the Innovative Medicines Fund and NICE Methods and Process Review can together improve access to new medicines for patients with rare diseases.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 June 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of how the Innovative Medicines Fund and NICE Methods and Process Review can together improve access to new medicines for patients with rare diseases.
Source: Commons
1 July 2021
Answer
The Department regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England and NHS Improvement, including NICE’s methods review. However, NICE is an independent body and is responsibl...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-06-25/22191
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1340255
- uk · wq-1340255 · source updated 1 July 2021